Jordan Miller is a pharmacist who is specialized in Oncology in Chapel Hill, North Carolina. Patients can reach him at 101 Manning Dr, Chapel Hill or contact him on 984-974-8241. Active license number of Jordan Miller is 25932 for Oncology in North Carolina. Jordan Miller is a licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.
Complete Profile:
Jordan Miller speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
Name:
Jordan Miller
Specialization:
Oncology
Credentials:
PHARMD
Gender:
Male
Location:
101 Manning Dr, Chapel Hill, North Carolina, 27514-4220
Phone:
984-974-8241
Fax:
919-966-0304
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Jordan Miller are as mentioned below.
NPI Number:
1033560644
NPI Enumeration Date:
24 Jun, 2016
NPI Last Update On:
24 Jun, 2016
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Jordan Miller are as mentioned below.
Specialization
License Number
State
Status
Oncology
25932
North Carolina
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
101 Manning Dr, Chapel Hill, North Carolina
Zip:
27514-4220
Phone Number:
984-974-8241
Fax Number:
919-966-0304
Patients can reach Jordan Miller at 101 Manning Dr, Chapel Hill, North Carolina or can call on phone at 984-974-8241.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 14 October, 2024.